Page last updated: 2024-08-18

tetradifon and Diabetes Mellitus, Type 2

tetradifon has been researched along with Diabetes Mellitus, Type 2 in 1 studies

*Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Badraoui, R; Bardakçi, F; Ben-Nasr, H; Rebai, T1

Other Studies

1 other study(ies) available for tetradifon and Diabetes Mellitus, Type 2

ArticleYear
Pathophysiological impacts of exposure to an endocrine disruptor (tetradifon) on α-amylase and lipase activities associated metabolic disorders.
    Pesticide biochemistry and physiology, 2020, Volume: 167

    Topics: alpha-Amylases; Animals; Diabetes Mellitus, Type 2; Endocrine Disruptors; Hydrocarbons, Chlorinated; Lipase; Liver; Rats

2020